1. Home
  2. THAR vs JXG Comparison

THAR vs JXG Comparison

Compare THAR & JXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THAR
  • JXG
  • Stock Information
  • Founded
  • THAR 2017
  • JXG N/A
  • Country
  • THAR United States
  • JXG China
  • Employees
  • THAR N/A
  • JXG N/A
  • Industry
  • THAR Biotechnology: Pharmaceutical Preparations
  • JXG
  • Sector
  • THAR Health Care
  • JXG
  • Exchange
  • THAR Nasdaq
  • JXG Nasdaq
  • Market Cap
  • THAR 5.5M
  • JXG 4.7M
  • IPO Year
  • THAR 2022
  • JXG N/A
  • Fundamental
  • Price
  • THAR $3.68
  • JXG $0.91
  • Analyst Decision
  • THAR Strong Buy
  • JXG
  • Analyst Count
  • THAR 1
  • JXG 0
  • Target Price
  • THAR $17.00
  • JXG N/A
  • AVG Volume (30 Days)
  • THAR 29.2M
  • JXG 118.3K
  • Earning Date
  • THAR 11-06-2025
  • JXG 05-15-2025
  • Dividend Yield
  • THAR N/A
  • JXG N/A
  • EPS Growth
  • THAR N/A
  • JXG N/A
  • EPS
  • THAR N/A
  • JXG 0.86
  • Revenue
  • THAR N/A
  • JXG $49,840,288.00
  • Revenue This Year
  • THAR N/A
  • JXG N/A
  • Revenue Next Year
  • THAR N/A
  • JXG N/A
  • P/E Ratio
  • THAR N/A
  • JXG $1.06
  • Revenue Growth
  • THAR N/A
  • JXG 56.53
  • 52 Week Low
  • THAR $0.95
  • JXG $0.55
  • 52 Week High
  • THAR $9.08
  • JXG $8.40
  • Technical
  • Relative Strength Index (RSI)
  • THAR 50.85
  • JXG 34.32
  • Support Level
  • THAR $4.94
  • JXG $0.92
  • Resistance Level
  • THAR $7.25
  • JXG $1.04
  • Average True Range (ATR)
  • THAR 1.50
  • JXG 0.08
  • MACD
  • THAR -0.08
  • JXG 0.01
  • Stochastic Oscillator
  • THAR 32.49
  • JXG 29.63

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

About JXG JX Luxventure Limited Common Stock

JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.

Share on Social Networks: